Plasmapheresis Device Market

Plasmapheresis Device Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Plasmapheresis Device Market – Overview
For instance, on September 2018, Shire plc. (SHP) acquired sanaplasma AG, augmenting plasma collection
network. The acquisition of sanaplasma AG is expected to increase Shire's access to plasma in the longer
term and also widens its European plasma collection network, complementing existing core capabilities in
plasma supply and manufacturing. This will also help to increase the customer base in the European region
which in turn will raise demand for Plasmapheresis devices in the market.
Moreover, Biotest Pharmaceuticals Corporation (BPC), a wholly owned subsidiary of Biotest US
Corporation, was acquired by Grifols Shared Services North America, Inc., in August 2018. This
acquisition comprises 22 BPC plasma collection centers that manufactures critical care therapies to treat
life threatening disorders. This acquisition of BPC will lead to increased availability of number of
resources for plasma collections and likely to stimulate the growth of plasmapheresis devices in the global
market.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Plasmapheresis Device Market : Regional Analysis
On the basis of region, the global plasmapheresis device market is segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
North America region is expected to dominate in the global plasmapheresis device market attributed to high
prevalence of autoimmune diseases which require frequent plasmapheresis tests. For instance, according to
American Autoimmune Related Diseases Association (AARDA) 2017 report, 50 million Americans are suffering
from autoimmune disorders.
European region is expected to witness significant growth rate due to increase in the development of
plasmapheresis devices. For instance, in October 2016, Fresenius Kabi, a company based in Germany, got FDA
approval for its Aurora Xi Plasmapheresis System. The device is designed to improve the process of blood plasma
collection, particularly speeding up the filtration process and allowing for more donors to donate in the same
amount of time.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2259
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Plasmapheresis Device Market: Key Players
●
Asahi Kasei Corporation
●
Terumo Corporation
●
Baxter International
●
B. Braun Melsungen AG
●
Kawasumi Laboratories
●
Kaneka Corporation
View this report @
https://www.coherentmarketinsights.com/ongoing-insight/plasmapheresis-device-market-2259
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

Plasmapheresis is a procedure in which blood is separated into cells and plasma (liquid). The plasma is then removed and replaced with fresh frozen plasma. It is done to treat variety of autoimmune disorders such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, sickle cell anemia, guillain-barre syndrome, and lambert- eaton myasthenic syndrome where autoantibodies are generated harming the body.